Human immunodeficiency virus neutralizing antibodies and methods of use thereof
US12071470B2 · kind B2 · utility
1Cited by
13References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 22, 2023 |
| Grant date | Aug 27, 2024 |
| Priority date | — |
| Expiry date | Feb 22, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides broadly neutralizing antibodies directed to epitopes of Human Immunodeficiency Virus, or HIV. The invention further provides compositions containing HIV antibodies used for prophylaxis, and methods for diagnosis and treatment of HIV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.